User menu

Cytolytic T-cell responses of cancer patients vaccinated with a MAGE antigen

Bibliographic reference Coulie, Pierre ; Godelaine, D. ; Karanikas, V ; Lurquin, C. ; Colau, Didier ; et. al. Cytolytic T-cell responses of cancer patients vaccinated with a MAGE antigen. In: Immunological Reviews, Vol. 188, p. 33-42 (2002)
Permanent URL
  1. Brasseur F, Int J Cancer, 63, 375 (1995)
  2. Boon T, Principles and practice of the biologic therapy of cancer., 493 (2000)
  3. van der Bruggen P, Science, 254, 1643 (1991)
  4. Boel P, Immunity, 2, 167 (1995)
  5. Van den Eynde B, J Exp Med, 182, 689 (1995)
  6. Tureci O, Cancer Res, 56, 4766 (1996)
  7. Chen Y.-T., Scanlan M. J., Sahin U., Tureci O., Gure A. O., Tsang S., Williamson B., Stockert E., Pfreundschuh M., Old L. J., A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening, 10.1073/pnas.94.5.1914
  8. Chen Michael E., Lin Sue-Hwa, Chung Leland W. K., Sikes Robert A., Isolation and Characterization ofPAGE-1andGAGE-7 : NEW GENES EXPRESSED IN THE LNCaP PROSTATE CANCER PROGRESSION MODEL THAT SHARE HOMOLOGY WITH MELANOMA-ASSOCIATED ANTIGENS, 10.1074/jbc.273.28.17618
  9. Lethé Bernard, Lucas Sophie, Michaux Lucienne, De Smet Charles, Godelaine Danièle, Serrano Alfonso, De Plaen Etienne, Boon Thierry, LAGE-1, a new gene with tumor specificity, 10.1002/(sici)1097-0215(19980610)76:6<903::aid-ijc22>;2-1
  10. Uyttenhove Catherine, Godfraind Catherine, Lethé Bernard, Amar-Costesec Alain, Renauld Jean-Christophe, Gajewski Thomas F., Duffour Marie-Thérèse, Warnier Guy, Boon Thierry, Van den Eynde Benoît J., The expression of mouse geneP1A in testis does not prevent safe induction of cytolytic T cells against a P1A-encoded tumor antigen, 10.1002/(sici)1097-0215(19970127)70:3<349::aid-ijc17>;2-a
  11. Chaux P, J Immunol, 163, 2928 (1999)
  12. Chaux Pascal, Vantomme Valérie, Stroobant Vincent, Thielemans Kris, Corthals Jurgen, Luiten Rosalie, Eggermont Alexander M.M., Boon Thierry, van der Bruggen Pierre, Identification of MAGE-3 Epitopes Presented by HLA-DR Molecules to CD4+T Lymphocytes, 10.1084/jem.189.5.767
  13. 13. B Van den Eynde, and P van der Bruggen . Peptide database of T-cell defined tumor antigens . Cancer Immunity. 2001 .
  14. Marchand Marie, van Baren Nicolas, Weynants Patrick, Brichard Vincent, Dr�no Brigitte, Tessier Marie-H�l�ne, Rankin Elaine, Parmiani Giorgio, Arienti Flavio, Humblet Yves, Bourlond Andr�, Vanwijck Romain, Li�nard Danielle, Beauduin Marc, Dietrich Pierre-Yves, Russo Vincenzo, Kerger Joseph, Masucci Giuseppe, J�ger Elke, De Greve Jacques, Atzpodien Jens, Brasseur Francis, Coulie Pierre G., van der Bruggen Pierre, Boon Thierry, Tumor regressions observed in patients with metastatic melanoma treated with an antigenic peptide encoded by geneMAGE-3 and presented by HLA-A1, 10.1002/(sici)1097-0215(19990118)80:2<219::aid-ijc10>;2-s
  15. Thurner Beatrice, Haendle Ina, Röder Claudia, Dieckmann Detlef, Keikavoussi Petra, Jonuleit Helmut, Bender Armin, Maczek Christian, Schreiner Doris, von den Driesch Peter, Bröcker Eva B., Steinman Ralph M., Enk Alexander, Kämpgen Eckhart, Schuler Gerold, Vaccination with Mage-3a1 Peptide–Pulsed Mature, Monocyte-Derived Dendritic Cells Expands Specific Cytotoxic T Cells and Induces Regression of Some Metastases in Advanced Stage IV Melanoma, 10.1084/jem.190.11.1669
  16. Baldo M, Plast Reconstr Surg, 90, 1073 (1992)
  17. Chaux Pascal, Vantomme Valérie, Coulie Pierre, Boon Thierry, van der Bruggen Pierre, Estimation of the frequencies of anti-MAGE-3 cytolytic T-lymphocyte precursors in blood from individuals without cancer, 10.1002/(sici)1097-0215(19980812)77:4<538::aid-ijc11>;2-2
  18. Westermann Jürgen, Pabst Reinhard, Lymphocyte subsets in the blood: a diagnostic window on the lymphoid system?, 10.1016/0167-5699(90)90160-b
  19. Marchand M, Int J Cancer, 63, 883 (1995)
  20. Altman J. D., Moss P. A. H., Goulder P. J. R., Barouch D. H., McHeyzer-Williams M. G., Bell J. I., McMichael A. J., Davis M. M., Phenotypic Analysis of Antigen-Specific T Lymphocytes, 10.1126/science.274.5284.94
  21. Coulie P. G., Karanikas V., Colau D., Lurquin C., Landry C., Marchand M., Dorval T., Brichard V., Boon T., A monoclonal cytolytic T-lymphocyte response observed in a melanoma patient vaccinated with a tumor-specific antigenic peptide encoded by gene MAGE-3, 10.1073/pnas.161260098
  22. Cadoz M., Meignier B., Plotkin S., Strady A., Taylor J., Tartaglia J., Paoletti E., Immunisation with canarypox virus expressing rabies glycoprotein, 10.1016/0140-6736(92)92027-d
  23. Paoletti E, Dev Biol Stand, 82, 65 (1994)
  24. Jager E., Gnjatic S., Nagata Y., Stockert E., Jager D., Karbach J., Neumann A., Rieckenberg J., Chen Y.-T., Ritter G., Hoffman E., Arand M., Old L. J., Knuth A., Induction of primary NY-ESO-1 immunity: CD8+ T lymphocyte and antibody responses in peptide-vaccinated patients with NY-ESO-1+ cancers, 10.1073/pnas.220413497
  25. Baurain J.-F., Colau D., van Baren N., Landry C., Martelange V., Vikkula M., Boon T., Coulie P. G., High Frequency of Autologous Anti-Melanoma CTL Directed Against an Antigen Generated by a Point Mutation in a New Helicase Gene, 10.4049/jimmunol.164.11.6057
  26. Karanikas V, Cancer Research, 61, 3718 (2001)
  27. Wilson Jamie D.K., Ogg Graham S., Allen Rachel L., Goulder Philip J.R., Kelleher Anthony, Sewell Andy K., O'Callaghan Christopher A., Rowland-Jones Sarah L., Callan Margaret F.C., McMichael Andrew J., Oligoclonal Expansions of CD8+T Cells in Chronic HIV Infection Are Antigen Specific, 10.1084/jem.188.4.785
  28. Weekes MP, J Virol, 73, 2099 (1999)
  29. Weekes MP, J Immunol, 162, 7569 (1999)
  30. Luiten R.M., Demotte N., Tine J., van der Bruggen P., A MAGE-A1 peptide presented to cytolytic T lymphocytes by both HLA-B35 and HLA-A1 molecules, 10.1034/j.1399-0039.2000.560110.x
  31. Schultz E.S., Zhang Y., Knowles R., Tine J., Traversari C., Boon T., van der Bruggen P., A MAGE-3 peptide recognized on HLA-B35 and HLA-A1 by cytolytic T lymphocytes, 10.1034/j.1399-0039.2001.057002103.x
  32. del Guercio M-F, J Immunol, 154, 685 (1995)
  33. Bourgault Villada Isabelle, Bénéton Nathalie, Bony Claire, Connan Francine, Monsonego Jean, Bianchi Anne, Saiag Philippe, Lévy Jean Paul, Guillet Jean Gérard, Choppin Jeannine, Identification in humans of HPV-16 E6 and E7 protein epitopes recognized by cytolytic T lymphocytes in association with HLA-B18 and determination of the HLA-B18-specific binding motif, 10.1002/1521-4141(2000)30:8<2281::aid-immu2281>;2-n
  34. Tomiyama Hiroko, Yamada Naoyuki, Komatsu Hiroki, Hirayama Kazuo, Takiguchi Masafumi, A single CTL clone can recognize a naturally processed HIV-1 epitope presented by two different HLA class I molecules, 10.1002/1521-4141(200009)30:9<2521::aid-immu2521>;2-q
  35. Wang R-F, J Immunol, 160, 890 (1998)
  36. Thimme R., Chang K.-M., Pemberton J., Sette A., Chisari F. V., Degenerate Immunogenicity of an HLA-A2-Restricted Hepatitis B Virus Nucleocapsid Cytotoxic T-Lymphocyte Epitope That Is Also Presented by HLA-B51, 10.1128/jvi.75.8.3984-3987.2001
  37. Maryanski JL, Eur J Immunol, 12, 401 (1982)
  38. Yamshchikov Galina V., Barnd Donna L., Eastham Shannon, Galavotti Holly, Patterson James W., Deacon Donna H., Teates David, Neese Patrice, Grosh William W., Petroni Gina, Engelhard Victor H., Slingluff Jr. Craig L., Evaluation of peptide vaccine immunogenicity in draining lymph nodes and peripheral blood of melanoma patients, 10.1002/1097-0215(20010601)92:5<703::aid-ijc1250>;2-5
  39. Sallusto Federica, Lenig Danielle, Förster Reinhold, Lipp Martin, Lanzavecchia Antonio, Two subsets of memory T lymphocytes with distinct homing potentials and effector functions, 10.1038/44385
  40. Lehmann Paul V., Forsthuber Thomas, Miller Alexander, Sercarz Eli E., Spreading of T-cell autoimmunity to cryptic determinants of an autoantigen, 10.1038/358155a0
  41. Van Pel A, Proc Natl Acad Sci USA, 79, 4718 (1982)
  42. Boon T, Proc Natl Acad Sci USA, 75, 1519 (1978)